rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Susan B. Hirsch

Director

Company insider

Files Form 4 as: Director, Agenus; Director, Tecogen.

In numbers

Trades disclosed
39
Buys
3
Sells
0
Bought
$93K
Sold
$0
Companies
2
Companies where not an officer
2
First trade
8 Oct 2020
Last trade
5 Aug 2026
Last filed
7 Aug 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
AGEN AgenusDirector · Biotechnology · last 5 Aug 20260 buys · 0 sells
TGEN TecogenDirector · Machinery · last 26 Jun 20263 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
01Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
5 Aug 2026filed 7 Aug 2026AGEN Agenusoption or derivative · BiotechnologySEC FORM 4 Code A—50,000 at $0.00filing
5 Aug 2026filed 7 Aug 2026AGEN Agenusoption or derivative · BiotechnologySEC FORM 4 Code A—50,000 at $0.00filing
26 Jun 2026filed 30 Jun 2026TGEN Tecogenoption or derivative · MachinerySEC FORM 4 Code A$129K25,000 at $5.17filing
26 Jun 2026filed 30 Jun 2026TGEN Tecogenoption or derivative · MachinerySEC FORM 4 Code A$129K25,000 at $5.17filing
24 Apr 2026filed 28 Apr 2026AGEN Agenusoption or derivative · BiotechnologySEC FORM 4 Code A—105,000 at $0.00filing
24 Apr 2026filed 28 Apr 2026AGEN Agenusoption or derivative · BiotechnologySEC FORM 4 Code A—105,000 at $0.00filing
13 Apr 2026filed 14 Apr 2026TGEN TecogenMachinerySEC FORM 4 Bought$19K5,000 at $3.73filing
13 Apr 2026filed 14 Apr 2026TGEN TecogenMachinerySEC FORM 4 Bought$19K5,000 at $3.73filing
27 Mar 2026filed 27 Mar 2026TGEN TecogenMachinerySEC FORM 4 Bought$25K10,000 at $2.54filing
27 Mar 2026filed 27 Mar 2026TGEN TecogenMachinerySEC FORM 4 Bought$25K10,000 at $2.54filing
24 Jul 2025filed 28 Jul 2025TGEN Tecogenoption or derivative · MachinerySEC FORM 4 Code A$209K25,000 at $8.35filing
17 Jun 2025filed 20 Jun 2025AGEN Agenusoption or derivative · BiotechnologySEC FORM 4 Code A—15,000 at $0.00filing
1 Jan 2025filed 2 Jan 2025AGEN Agenusoption or derivative · BiotechnologySEC FORM 4 Code A—6,416.07filing
1 Oct 2024filed 3 Oct 2024AGEN Agenusoption or derivative · BiotechnologySEC FORM 4 Code A—3,172.98filing
1 Jul 2024filed 1 Jul 2024AGEN Agenusoption or derivative · BiotechnologySEC FORM 4 Code A—1,827.96filing
6 Jun 2024filed 18 Jun 2024TGEN Tecogenoption or derivative · MachinerySEC FORM 4 Code A$19K25,000 at $0.77filing
1 Apr 2024filed 1 Apr 2024AGEN Agenusoption or derivative · BiotechnologySEC FORM 4 Code A—32,039.16filing
5 Feb 2024filed 22 Apr 2024AGEN Agenusoption or derivative · BiotechnologySEC FORM 4 Code A—5,000 at $0.00filing
2 Jan 2024filed 4 Jan 2024AGEN Agenusoption or derivative · BiotechnologySEC FORM 4 Code A—25,671.14filing
15 Nov 2023filed 12 Feb 2024AGEN AgenusBiotechnologySEC FORM 4 Code L$3,7505,000 at $0.75filing

News

Tecogen, Inc.: Data Center Cuts Electric Bills Substantially with Tecogen's InVerdeTGEN · finanznachrichten.de · 14 Oct 2026

0 headlines in the last 90 days name Susan B. Hirsch; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.

Sectors

Industrials3

Buys in green, sells in red, by the company’s sector.

Related people

Thomas L. HarrisonDirector · Director at Agenus, filing Form 4 there in the last year
Timothy WrightDirector · Director at Agenus, filing Form 4 there in the last year
Marco Tullio MarcucciDirector · Director at Agenus, filing Form 4 there in the last year
Robert PanoraCOO and President · COO and President at Tecogen, filing Form 4 there in the last year
Roger P. DeschenesChief Financial Officer · Chief Financial Officer at Tecogen, filing Form 4 there in the last year